Patents by Inventor Vincent Guerlavais

Vincent Guerlavais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080279868
    Abstract: The present disclosure provides antibody-drug conjugates that are potent cytotoxins, wherein the drug is linked to the antibody through a linker. The disclosure is also directed to compositions containing the antibody-drug conjugates, and to methods of treatment using them.
    Type: Application
    Filed: September 26, 2006
    Publication date: November 13, 2008
    Applicant: Medarex, Inc.
    Inventors: Sharon Elaine Boyd, Liang Chen, Sanjeev Gangwar, Vincent Guerlavais, Kilian Horgan, Bilal Sufi, Haichun Huang, David John King, Chin Pan, Josephine M. Cardarelli
  • Patent number: 7297681
    Abstract: The invention relates to compounds of formula I which are useful for elevating the plasma level of growth hormone in a mammal as well as for the treatment of growth hormone secretion deficiency, growth retardation in child and metabolic disorders associated with growth hormone secretion deficiency.
    Type: Grant
    Filed: May 4, 2004
    Date of Patent: November 20, 2007
    Assignee: Æterna Zentaris GmbH
    Inventors: Jean Martinez, Jean-Alain Fehrentz, Vincent Guerlavais
  • Publication number: 20060024317
    Abstract: The present disclosure provides drug-ligand conjugates that are potent cytotoxins, wherein the drug is linked to the ligand through either a peptidyl, hydrazine, or disulfide linker. The disclosure is also directed to compositions containing the drug-ligand conjugates, and to methods of treatment using them.
    Type: Application
    Filed: May 19, 2005
    Publication date: February 2, 2006
    Applicant: Medarex, Inc
    Inventors: Sharon Boyd, Liang Chen, Sanjeev Gangwar, Vincent Guerlavais, Killian Horgan, Zhi-Hong Li, Bilal Sufi
  • Publication number: 20060004081
    Abstract: The present disclosure provides drug-cleavable substrate conjugates that are potent cytotoxins. The disclosure is also directed to compositions containing the drug-cleavable substrate conjugates, and to methods of treatment using them.
    Type: Application
    Filed: May 19, 2005
    Publication date: January 5, 2006
    Applicant: Medarex, Inc.
    Inventors: Liang Chen, Sanjeev Gangwar, Vincent Guerlavais, Zhi-Hong Li, Bilal Sufi
  • Patent number: 6861409
    Abstract: The invention relates to compounds of formula I which are useful for elevating the plasma level of growth hormone in a mammal as well for the treatment of growth hormone secretion deficiency, growth retardation in child and metabolic disorders associated with growth hormone secretion deficiency.
    Type: Grant
    Filed: June 13, 2001
    Date of Patent: March 1, 2005
    Assignee: Zentaris AG
    Inventors: Jean Martinez, Jean-Alain Fehrentz, Vincent Guerlavais
  • Publication number: 20040229823
    Abstract: The invention relates to compounds of formula I 1
    Type: Application
    Filed: May 4, 2004
    Publication date: November 18, 2004
    Applicant: Zentaris AG
    Inventors: Jean Martinez, Jean-Alain Fehrentz, Vincent Guerlavais
  • Publication number: 20020165343
    Abstract: The invention relates to compounds of formula I 1
    Type: Application
    Filed: June 13, 2001
    Publication date: November 7, 2002
    Inventors: Jean Martinez, Jean-Alain Fehrentz, Vincent Guerlavais